CZ420598A3 - Indolinový derivát k použití jako antagonista 5-HT-2C receptoru - Google Patents

Indolinový derivát k použití jako antagonista 5-HT-2C receptoru Download PDF

Info

Publication number
CZ420598A3
CZ420598A3 CZ984205A CZ420598A CZ420598A3 CZ 420598 A3 CZ420598 A3 CZ 420598A3 CZ 984205 A CZ984205 A CZ 984205A CZ 420598 A CZ420598 A CZ 420598A CZ 420598 A3 CZ420598 A3 CZ 420598A3
Authority
CZ
Czechia
Prior art keywords
compound
methyl
compound according
yloxy
formula
Prior art date
Application number
CZ984205A
Other languages
Czech (cs)
English (en)
Inventor
Steven Mark Bromidge
Ian Thompson Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CZ420598A3 publication Critical patent/CZ420598A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ984205A 1996-06-20 1997-06-16 Indolinový derivát k použití jako antagonista 5-HT-2C receptoru CZ420598A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
CZ420598A3 true CZ420598A3 (cs) 1999-06-16

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ984205A CZ420598A3 (cs) 1996-06-20 1997-06-16 Indolinový derivát k použití jako antagonista 5-HT-2C receptoru

Country Status (33)

Country Link
US (1) US6369060B1 (enExample)
EP (1) EP0912554B1 (enExample)
JP (1) JP2000512306A (enExample)
KR (1) KR20000022045A (enExample)
CN (1) CN1229408A (enExample)
AP (2) AP9801410A0 (enExample)
AR (1) AR008243A1 (enExample)
AT (1) ATE228514T1 (enExample)
AU (1) AU718597B2 (enExample)
BG (1) BG103089A (enExample)
BR (1) BR9709911A (enExample)
CA (1) CA2258240A1 (enExample)
CO (1) CO4890847A1 (enExample)
CZ (1) CZ420598A3 (enExample)
DE (1) DE69717449T2 (enExample)
DZ (1) DZ2250A1 (enExample)
EA (1) EA001780B1 (enExample)
ES (1) ES2187783T3 (enExample)
GB (1) GB9612883D0 (enExample)
HU (1) HUP9903439A3 (enExample)
ID (1) ID19433A (enExample)
IL (1) IL127417A0 (enExample)
MA (1) MA24214A1 (enExample)
NO (1) NO985972D0 (enExample)
NZ (1) NZ333229A (enExample)
OA (1) OA10944A (enExample)
PE (1) PE86698A1 (enExample)
PL (1) PL330796A1 (enExample)
SK (1) SK282706B6 (enExample)
TR (1) TR199802661T2 (enExample)
TW (1) TW382015B (enExample)
WO (1) WO1997048699A1 (enExample)
ZA (1) ZA975415B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
BR0214529A (pt) 2001-11-28 2006-05-30 Upjohn Co compostos terapêuticos
CA2475254A1 (en) * 2002-03-04 2003-09-18 Pharmacia & Upjohn Company Pyridinyloxy derivatives as 5-ht receptor ligands
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
JP2012515202A (ja) 2009-01-16 2012-07-05 マサチューセッツ インスティテュート オブ テクノロジー 自閉症圏障害の診断および処置
JP2013545792A (ja) 2010-12-17 2013-12-26 グラクソ グループ リミテッド 眼疾患の処置および防止方法
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
WO1994004533A1 (en) * 1992-08-20 1994-03-03 Smithkline Beecham Plc Condensed indole derivatives as 5ht2c and 5ht2b antagonists
GB9313913D0 (en) 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
WO1996023783A1 (en) * 1995-02-02 1996-08-08 Smithkline Beecham Plc Indole derivatives as 5-ht receptor antagonist
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
MA24214A1 (fr) 1997-12-31
ID19433A (id) 1998-07-09
DE69717449T2 (de) 2003-10-02
SK175298A3 (en) 1999-05-07
AP745A (en) 1999-04-28
SK282706B6 (sk) 2002-11-06
PE86698A1 (es) 1999-01-28
AU3260297A (en) 1998-01-07
DE69717449D1 (de) 2003-01-09
PL330796A1 (en) 1999-06-07
ATE228514T1 (de) 2002-12-15
AP9701037A0 (en) 1997-07-31
CN1229408A (zh) 1999-09-22
NZ333229A (enExample) 2000-01-28
JP2000512306A (ja) 2000-09-19
CA2258240A1 (en) 1997-12-24
EA001780B1 (ru) 2001-08-27
TW382015B (en) 2000-02-11
EP0912554B1 (en) 2002-11-27
BG103089A (en) 1999-09-30
KR20000022045A (ko) 2000-04-25
NO985972L (no) 1998-12-18
US6369060B1 (en) 2002-04-09
TR199802661T2 (xx) 1999-03-22
HUP9903439A3 (en) 2002-12-28
EA199900043A1 (ru) 1999-06-24
AP9801410A0 (en) 1998-12-31
IL127417A0 (en) 1999-10-28
ES2187783T3 (es) 2003-06-16
GB9612883D0 (en) 1996-08-21
CO4890847A1 (es) 2000-02-28
DZ2250A1 (fr) 2002-12-18
ZA975415B (en) 1998-12-21
NO985972D0 (no) 1998-12-18
EP0912554A1 (en) 1999-05-06
AR008243A1 (es) 1999-12-29
HUP9903439A2 (en) 2000-07-28
WO1997048699A1 (en) 1997-12-24
AU718597B2 (en) 2000-04-20
BR9709911A (pt) 1999-08-10
OA10944A (en) 2003-02-27

Similar Documents

Publication Publication Date Title
EP1448560B1 (en) 3-SUBSTITUTED OXINDOLE beta 3 AGONISTS
KR0174752B1 (ko) 이환식 헤테로환 함유 술폰아미드 유도체 및 그 제조방법
US8481745B2 (en) N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use therof
US5866586A (en) CNS-active pyridinylurea derivatives
WO1997008167A1 (en) 5ht2c and 5ht2b antagonists
US6313145B1 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
CZ420598A3 (cs) Indolinový derivát k použití jako antagonista 5-HT-2C receptoru
NZ548949A (en) Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
WO1998052943A1 (en) Indoline derivatives as 5ht2c receptor antagonists
KR20000029564A (ko) 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물
KR100486795B1 (ko) 5-ht-2c수용체길항제로유용한인돌린유도체
HK1019744B (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
KR100282153B1 (ko) 3-알킬피롤록3,2-씨퀴놀린유도체
JPWO1997032854A1 (ja) ２−スルフィニルニコチンアミド誘導体、その中間体および２−スルフィニルニコチンアミド誘導体の製造方法並びに該化合物を有効成分とする医薬組成物

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic